- 200 mg
- 300 mg
- Others
Quinine Market size was valued at USD 1,783.9 million in 2023 and is poised to grow at a CAGR of 6.1% from 2024 - 2030. Quinine is a medication that is derived from the bark of the cinchona tree. Primarily used to treat malaria and babesiosis, specifically caused by Plasmodium falciparum. It can also be used to treat other conditions like leg cramps. While synthetic antimalarial drugs have largely replaced quinine as the first-line treatment for malaria, quinine continues to play a significant role in malaria management, particularly in regions where drug resistance is prevalent. The FDA has only approved it for treating malaria, but doctors can legally prescribe it for any type of treatment they deem appropriate.
The global quinine market refers to the worldwide production and consumption of quinine. This market encompasses various activities related to the extraction, processing, distribution, and sale of quinine and quinine-based products. The primary driver is the demand for quinine in the pharmaceutical industry, especially for treating malaria in regions where the disease is prevalent. Moreover, it is used in photochemistry as a popular fluorescence standard, which can propel market growth. Quinine is used to flavor tonic water as well as bitter lemon drink mixers, which is projected to grow tremendously. It’s one of the main ingredients in some alcoholic beverages such as gin which will also act as a driving factor of the market. Restraints include side effects such as nausea and dizziness, availability of alternative antimalarial drugs, such as artemisinin-based combination therapies (ACTs), and supply chain disruptions because of the dependency on cinchona trees. However, many countries, including the UK have banned the use of Quinine sulphate to treat malaria, which may impede market growth. Increasing healthcare access in developing countries, the rising popularity of craft beverages and premium tonic waters, and sustainable and ethical sourcing of cinchona bark present growth opportunities for quinine-based antimalarial treatments.
Recent Development In The Global Quinine Market :
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
According to WHO, nearly half of the world’s population is at risk of malaria. In 2022, an estimated 249 million people contracted malaria in 85 countries. That same year, the disease claimed approximately 608,000 lives. Further stated four sub-Saharan African countries reported the highest number of deaths caused by malaria. These include Nigeria, the Democratic Republic of Congo, the United Republic of Tanzania, and Mozambique. The rising number of malaria incidences in the region is a prime factor fueling the demand for Quinine in the Middle East & Africa region. Over time, tonic water evolved from a medicinal drink to a popular mixer in cocktails, especially with gin, leading to the classic gin and tonic. Modern consumers are increasingly seeking high-quality, premium products. This trend is evident in the beverage industry, where there is a growing demand for premium tonic waters that use natural quinine and high-quality ingredients. The companies compete to provide the most natural possible premium tonic waters. These brands often emphasize the natural origin of their quinine, the use of organic sweeteners, and unique botanical blends, appealing to discerning consumers
Global Quinine Market size was valued at USD XX billion in 2023 and is poised to grow at a CAGR of XX% from 2024-2030.
Major companies operating within the Global Quinine Market are Aecochem Corp, Haihang Industry Co. Ltd, Actavis, Shreeji Pharma International, Wockhardt, B. Enterprises
Drivers for the global quinine market are in the pharmaceutical industry, especially for treating malaria in regions where the disease is prevalent. Moreover, it is used in photochemistry as a popular fluorescence standard, which can propel market growth. Quinine is used to flavor tonic water as well as bitter lemon drinks which also acts as a driving factor
North America, particularly the United States, leads in the Global Quinine Market due to the adoption of advanced genetic engineering technologies, including CRISPR/Cas9 and next-generation sequencing, and the presence of research institutions, universities, and biotechnology companies with significant investments in R&D activities
Hospitals and Clinics dominate other segments in the Global Quinine Market.
1.Executive Summary |
2. Global Quinine Market Introduction |
2.1.Global Quinine Market - Taxonomy |
2.2.Global Quinine Market - Definitions |
2.2.1.Dosage |
2.2.2.Administration |
2.2.3.Application |
2.2.4.End Users |
2.2.5.Region |
3. Global Quinine Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Quinine Market Analysis, 2019 - 2023 and Forecast 2024 -2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Quinine Market By Dosage, 2019 - 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
5.1. 200 mg |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. 300 mg |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Others |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6. Global Quinine Market By Administration, 2019 - 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
6.1. Oral |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Intramuscular |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Intravenous |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Others |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7. Global Quinine Market By Application, 2019 - 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
7.1. Anti-Malarial |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Problematic Leg Cramps |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Anti-pyretic |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8.Global Quinine Market By End Users, 2019 - 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
8.1. Hospitals and Clinics |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Research Organizations |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Others |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
9.Global Quinine Market By Region, 2019 - 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10.North America Quinine Market ,2019 - 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
10.1. Dosage Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.200 mg |
10.1.2.300 mg |
10.1.3.Others |
10.2. Administration Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Oral |
10.2.2.Intramuscular |
10.2.3.Intravenous |
10.2.4.Others |
10.3. Application Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Anti-Malarial |
10.3.2.Problematic Leg Cramps |
10.3.3.Anti-pyretic |
10.4. End Users Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Hospitals and Clinics |
10.4.2.Research Organizations |
10.4.3.Others |
10.5. Country Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11. Europe Quinine Market ,2019 - 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
11.1. Dosage Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.200 mg |
11.1.2.300 mg |
11.1.3.Others |
11.2. Administration Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Oral |
11.2.2.Intramuscular |
11.2.3.Intravenous |
11.2.4.Others |
11.3. Application Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Anti-Malarial |
11.3.2.Problematic Leg Cramps |
11.3.3.Anti-pyretic |
11.4. End Users Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Hospitals and Clinics |
11.4.2.Research Organizations |
11.4.3.Others |
11.5. Country Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
11.5.6.Rest of EU |
12.Asia Pacific (APAC) Quinine Market ,2019 - 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
12.1. Dosage Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.200 mg |
12.1.2.300 mg |
12.1.3.Others |
12.2. Administration Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Oral |
12.2.2.Intramuscular |
12.2.3.Intravenous |
12.2.4.Others |
12.3. Application Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Anti-Malarial |
12.3.2.Problematic Leg Cramps |
12.3.3.Anti-pyretic |
12.4. End Users Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Hospitals and Clinics |
12.4.2.Research Organizations |
12.4.3.Others |
12.5. Country Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13.Middle East and Africa (MEA) Quinine Market ,2019 - 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
13.1. Dosage Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.200 mg |
13.1.2.300 mg |
13.1.3.Others |
13.2. Administration Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Oral |
13.2.2.Intramuscular |
13.2.3.Intravenous |
13.2.4.Others |
13.3. Application Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Anti-Malarial |
13.3.2.Problematic Leg Cramps |
13.3.3.Anti-pyretic |
13.4. End Users Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Hospitals and Clinics |
13.4.2.Research Organizations |
13.4.3.Others |
13.5. Country Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14.Latin America Quinine Market ,2019 - 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
14.1. Dosage Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.200 mg |
14.1.2.300 mg |
14.1.3.Others |
14.2. Administration Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Oral |
14.2.2.Intramuscular |
14.2.3.Intravenous |
14.2.4.Others |
14.3. Application Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Anti-Malarial |
14.3.2.Problematic Leg Cramps |
14.3.3.Anti-pyretic |
14.4. End Users Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Hospitals and Clinics |
14.4.2.Research Organizations |
14.4.3.Others |
14.5. Country Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.Actavis |
15.2.2.Aecochem Corp |
15.2.3.B. Enterprises |
15.2.4.Bickford & Sons |
15.2.5.Caraco Pharmaceutical Laboratories |
15.2.6.Chempro Pharma Private Limited |
15.2.7.Cinchona Industries |
15.2.8.Fever-Tree |
15.2.9.GSK |
15.2.10.Haihang Industry Co. Ltd. |
15.2.11.Hangzhou Dayang Co. Ltd. |
15.2.12.IS Chemical Technology Ltd. |
15.2.13.Leocorno Enterprises |
15.2.14.Sanofi |
15.2.15.Schweppes |
15.2.16.Shreeji Pharma International |
15.2.17.Trademax Pharmaceuticals & Chemicals |
15.2.18.Wockhardt |
16. Research Methodology |
17. Appendix and Abbreviations |